This inventor holds 3 USPTO granted patents. Top assignees: University of California, Cor Therapeutics, Inc.. Active years: 1997-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 16,035 
2 out of 92 Years Active: 1997-1999
Title: James E Tomlinson: Innovator in Platelet-Derived Growth Factor Research
Introduction
James E Tomlinson is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biochemistry, particularly in the study of human platelet-derived growth factor receptors. With a total of 3 patents, his work has advanced the understanding of receptor polypeptides and their applications.
Latest Patents
Tomlinson's latest patents include innovative methods for utilizing domains of the extracellular region of human-defined constructs of modified human platelet-derived growth factor receptor polypeptides. These patents detail the identification of extracellular region domain structures and the modifications and combinatorial rearrangements of receptor segments. Both cell-bound and soluble forms of modified segments are made available, along with methods for assays that facilitate the screening of ligand analogues. Another significant patent involves antibodies that bind to epitopes of human platelet-derived growth factor receptor fragments, specifically targeting regions from extracellular domains D1, D2, and D3. This invention also includes monoclonal antibodies directed to the intra-cysteine portion of domain D3.
Career Highlights
Throughout his career, Tomlinson has worked with esteemed institutions such as the University of California and Cor Therapeutics, Inc. His research has been pivotal in advancing therapeutic approaches related to platelet-derived growth factors.
Collaborations
Tomlinson has collaborated with notable professionals in his field, including David Lawrence Wolf and Larry J Fretto. Their combined expertise has contributed to the success of various research initiatives.
Conclusion
James E Tomlinson's innovative work in the realm of platelet-derived growth factor receptors has led to significant advancements in biochemistry. His patents and collaborations reflect a commitment to enhancing scientific understanding and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile